Clinical Trial

Diabetes Self-management With Continuous Glucose Monitoring

Study acronym: DIASELF
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 11, 2024 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.
Summary
The overall goal of this observational study is to investigate the interaction between people with type 1 diabetes and continuous glucose monitoring (CGM) and the impact of this interaction on quality of life, particularly the level of diabetes distress, and glycaemic metrics. Participants will: * Visit the clinic twice with a 14-day interval * Fill out a survey before the first and at the last visit * Use CGM as usual and use smart insulin pens and an activity tracker * Register food intake * Answer two-three questions twice a day in REDCap
Trial Details
NCT Number NCT06453434
Lead Sponsor Nordsjaellands Hospital
Collaborators: Steno Diabetes Center Copenhagen
Conditions Type 1 Diabetes
Enrollment 500 participants
Start Date 2024-07-01
Primary Completion 2025-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2024-06-11